Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ADENOSINE vs ADO-TRASTUZUMAB EMTANSINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ADENOSINE vs ADO-TRASTUZUMAB EMTANSINE: Safety Overview

Metric ADENOSINE ADO-TRASTUZUMAB EMTANSINE
Total FAERS Reports 706 8,699
Deaths Reported 30 1,199
Death Rate 4.2% 13.8%
Hospitalizations 309 2,608
Average Patient Age 46.0 yrs 54.8 yrs
% Female Patients 48.2% 96.8%
FDA Approval Date Apr 16, 2018 N/A
Manufacturer NOKSIBCHO cosmetic Co., Ltd. N/A
Route TOPICAL N/A
Marketing Status Discontinued Prescription